Amylyx Pharmaceuticals Inc Free Cash Flow Generation Index

Latest as of December 2023: 0.97x

Amylyx Pharmaceuticals Inc free cash flow generation index. Amylyx Pharmaceuticals Inc (AMLX) has a Free Cash Flow Generation Index of 0.97x as of December 2023. Free cash flow of $13.20 Million represents 1% of operating cash flow ($13.55 Million).

FCF Generation Index

0.97x
Free Cash Flow / Operating CF

Free Cash Flow

$13.20 Million
USD

Operating Cash Flow

$13.55 Million
USD

Capital Expenditures

$356.00K
USD

Free Cash Flow Generation Index of Amylyx Pharmaceuticals Inc (2023–2023)

Free cash flow generation index of Amylyx Pharmaceuticals Inc from 2023 to 2023. Historical FCF Generation Index trend for Amylyx Pharmaceuticals Inc across 1 annual periods. See Amylyx Pharmaceuticals Inc leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Amylyx Pharmaceuticals Inc Free Cash Flow Generation Index by Year (2023–2023)

Amylyx Pharmaceuticals Inc free cash flow generation index by year from 2023 to 2023. Year-by-year Free Cash Flow Generation Index for Amylyx Pharmaceuticals Inc. For the full cash flow conversion analysis, see AMLX cash flow conversion.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.90x $10.68 Million $11.92 Million $1.24 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).